Mylan Laboratories has acquired 1 company of its own.
Mylan Laboratories’ largest acquisition to date was in 1998, when it acquired Penederm for $205M. Mylan Laboratories has acquired in 1 US state. The Company’s most targeted sectors include life science (100%).
1-1-151/1, 4th Floor, Sai Ram Towers,
Secunderabad,
India,
www.mylanlabs.in
| Date | Target |
Value
$mlns |
Transaction Type | Acquirer | Seller |
SRC
Link |
|---|---|---|---|---|---|---|
| 1998-06-24 |
Penederm, Inc. · Life Science
Foster City, California Penederm, Inc. develops and markets patented topically administered prescription products. The company currently markets three prescription products to dermatologists in the U.S. through a 41 person direct sales force. |
205 | Add-on Acquisition | - | - |
Unlimited Searches Unlimited Profile Views Build and Export Lists of
Mergr is a user-friendly database designed to simplify the complex world of private equity and M&A for busy professionals.
We created Mergr to eliminate the challenge of tracking company acquisitions, sales, and ownership, providing clear insights into investment firms and their activities. For example, explore an investment firm’s investment criteria, deal history, portfolio, and connections - organized to help you uncover opportunities and make informed decisions.
With Mergr, gain access to a comprehensive, interconnected web of transactions, investors, companies, and advisors - all in one place.
Full access to Mergr's investor, acquirer, and transaction data starts here.
